SEC Form 4 · accession 0001209191-16-130132
SPECTRUM PHARMACEUTICALS INC · SPPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony E Maida III
Director
Period of report
Jun 27, 2016
Accepted (ET)
Jun 29, 2016 · 7:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000831547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jun 27, 2016 | F | 880 | $6.47 | D | 23,268 | D | |
| Common Stock, $0.001 par valueF1 | Jun 28, 2016 | F | 3,523 | $6.33 | D | 19,745 | D | |
| Common Stock, $0.001 par valueF2 | Jun 28, 2016 | A | 10,000 | $0.00 | A | 29,745 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.33 | Jun 28, 2016 | A | 20,000 | A | — | Jun 28, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Represents restricted shares withheld by Spectrum to satisfy Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
- F2100% of the restricted shares shall vest on the earlier of (1) June 28, 2017 or (2) the date of the company's 2017 Annual Meeting of Shareholders.
- F325% of the option shares vested on June 28, 2016. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.